Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.
Wang JH, Deek MP, Mendes AA, Song Y, Shetty A, Bazyar S, Van der Eecken K, Chen E, Showalter TN, Royce TJ, Todorovic T, Huang HC, Houck SA, Yamashita R, Kiess AP, Song DY, Lotan T, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N, Berlin A, Onal C, Esteva A, Feng FY, Tran PT, Sutera P, Ost P.
Wang JH, et al. Among authors: tran pt.
Radiother Oncol. 2024 Nov 6;202:110618. doi: 10.1016/j.radonc.2024.110618. Online ahead of print.
Radiother Oncol. 2024.
PMID: 39510141